Bolivia vs Chile: Access to anti-retroviral drugs, female (%)
Bolivia
62.0%
in 2024
Chile
63.0%
in 2024
Bolivia rank
99th
Chile rank
96th
Access to anti-retroviral drugs, female (%) over time
- Bolivia
- Chile
How they compare
Chile currently reports 63.0% against 62.0% in Bolivia, a difference of 1.0%.
Across all 25 years both countries report, Chile has been ahead every year.
Bolivia ranks 99th and Chile ranks 96th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 29.7% | 27.6% | Chile |
| 2010s | 29.4% | 56.4% | 27.0% | Chile |
| 2020s | 57.6% | 65.6% | 8.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bolivia or Chile?
- Chile, at 63.0% against 62.0% in Bolivia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bolivia and Chile?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Bolivia and Chile?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia and Chile rank globally for access to anti-retroviral drugs, female?
- Bolivia ranks 99th and Chile ranks 96th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.